1. Most Discussed
  2. Gainers & Losers
SIE 4.6¢

looks oversold

  1. arthur

    7,396 Posts.


    Some pretty heavy selling lately by some large shareholders has knocked SIE down considerably

    With a strong buyer support level in the market depth at 6.3c ,

    A bounce off this level to support this company that looks like having a good increase in profits in the future could be possible.

    Has anybody seen any projected sales figures for the future on SIE .



    Ceasing to be a substantial holder


    HOMEX - Sydney

    AMP Limited ceased to be a substantial shareholder in SciGen Limited on 12/02/2003


    AMP Life Limited Holding was 6,575,350 2.51

    Ceasing to be a substantial holder from CBA


    HOMEX - Sydney

    Commonwealth Bank of Australia ceased to be a substantial shareholder
    in Scigen Limited on 10/12/2002.

    Becoming a substantial holder from CBA


    HOMEX - Sydney

    Commonwealth Bank of Australia became a substantial shareholder in
    Scigen Limited on 15/11/2002 with a relevant interest in the issued
    share capital of 42,876,308 fully paid ordinary shares (8.92%).


    SCIGEN LIMITED was admitted to ASX Friday, 15 Nov 2002.

    Official Quotation of the following securities on a deferred
    settlement basis will commence at 12:30pm EDST on Friday, 15 November

    232,243,574 ordinary shares fully paid issued at $0.20 per unit
    Pharmaceuticals & Biotechnology Capital $19

    Wednesday January 22,
    INTERVIEW: Siemens Medical Sees Faster Growth In China
    By Ramoncito dela Cruz

    SHANGHAI (Dow Jones)--Siemens Medical Solutions Group expects sales in China to grow more than 30% in the coming years as demand for better health care increases along with rising household incomes, senior executives of the Siemens AG (G.SIE) unit said Wednesday.

    "In the past three to five years, we have been growing by 30% per year (in China)...and we will be growing faster than 30% going forward," F. Steven Feinberg, general manager of Siemens Medical Solutions in China, told Dow Jones Newswires.

    Feinberg declined to say how much revenue his group, which sells medical equipment from hearing aids to computer tomography or CT scanners, generated last year.

    But Siemens Medical corporate vice president Gotz Steinhardt said China is the group's fastest growing market amid a slowdown in other major markets.

    Last year alone, the company tripled the number of its sales agents in China, as more hospitals and research institutes were investing heavily in advanced medical technology.

    "There's a tremendous pressure by the Chinese government for hospitals to improve the quality of health care," Feinberg said, adding that the entry of private clinics is also expected to boost sales.

    Richard Hausmann, president of Siemens' CT division, said Chinese themselves are demanding better health care, especially the burgeoning middle-class who are willing to shell out more money for better diagnosis and therapy.

    Seeking More Opportunities

    Hausmann said Siemens has developed a new CT scanner especially for the Chinese market, complete with Chinese language interface, in its 75%-owned Siemens Shanghai Medical Equipment Co. Ltd.

    As part of its expansion in China, Siemens Shanghai Medical has moved its facility to a larger area in the city's Pudong New Area. The new facility will also manufacture X-ray systems and other components for other medical equipment soon.

    Siemens Medical has invested EUR50 million so far in China.

    Aside from its Shanghai operations, it has a service and support center in Beijing, a hearing aid plant in Suzhou and a magnetic resonance imaging, or MRI, system plant in Shenzhen.

    Steinhardt said Siemens will continue to look for more business opportunities in China, including setting up more joint ventures to produce more types of imaging medical systems.

    Aside from medical equipment, Siemens Medical also offers information technology solutions for hospitals.

    Officials said sales of such solutions are also expected to increase in the coming years as more Chinese hospitals modernize their operations.

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.